DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
+1.54%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$266M
AUM Growth
+$266M
(+15%)
Cap. Flow
+$27.1M
Cap. Flow
% of AUM
10.17%
Top 10 Holdings %
Top 10 Hldgs %
46.64%
Holding
94
New
15
Increased
27
Reduced
15
Closed
6
Top Buys
| 1 |
ELOX
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
|
$3.74M |
| 2 |
Quince Therapeutics
QNCX
|
$2.78M |
| 3 |
TBIO
Translate Bio, Inc. Common Stock
TBIO
|
$2.25M |
| 4 |
EPZM
Epizyme, Inc
EPZM
|
$2.18M |
| 5 |
Accuray
ARAY
|
$2.03M |
Top Sells
| 1 |
GNCA
Genocea Biosciences, Inc.
GNCA
|
$4.92M |
| 2 |
VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
|
$1.59M |
| 3 |
ADXS
Advaxis, Inc.
ADXS
|
$1.2M |
| 4 |
Arbutus Biopharma
ABUS
|
$884K |
| 5 |
Savara
SVRA
|
$813K |
Sector Composition
| 1 | Healthcare | 91.5% |
